Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway as prognostic factors for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial tumors.

Joaquim Bellmunt,Jeffrey J Leow,Paul Van Hummelen,Lillian Werner,Jonathan E Rosenberg,Stephanie A Mullane,Markus Riester

doi:10.1200/jco.2014.32.15_suppl.4511

Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway as prognostic factors for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial tumors.

Joaquim Bellmunt, Jeffrey J Leow + Show 5 more

https://doi.org/10.1200/jco.2014.32.15_suppl.4511

Copy DOI

Journal: Journal of Clinical Oncology

Publication Date: May 20, 2014

Affiliation: Dana-Farber Brigham Cancer Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center

#Somatic Copy Number Abnormalities #Metastatic Urothelial Tumors + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

4511 Background: An integrative analysis was conducted to identify genomic alterations and mutational status on the gene pathway level that could predict OS in pts with urothelial cancers (UC) trea...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.